​

Funding Round

Venture Round - Ajax Therapeutics

Venture Round - Ajax Therapeutics

Investment Firm

Overview

Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.

Announced Date

Jun 01, 2021

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

N/A

Investor Lead

EcoR1 Capital

EcoR1 Capital

EcoR1 Capital is a early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

5

Investor Name
Participant InvestorBoxer Capital
Participant InvestorNYU Langone Health
Participant InvestorEcoR1 Capital
Participant InvestorMemorial Sloan - Kettering Cancer Center
Participant InvestorSchrödinger

Round Details and Background

Ajax Therapeutics raised $40000000 on 2021-06-01 in Venture Round

Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 01, 2021
Venture Round - Ajax Therapeutics
6-40.0M
May 13, 2024
Series C - Ajax Therapeutics
9-95.0M
Jun 28, 2019
Venture Round - Ajax Therapeutics
-8.0M

Recent Activity

There is no recent news or activity for this profile.